These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15650096)

  • 1. Induction of neutralizing antibodies in reindeer (Rangifer tarandus) after administration of a killed West Nile virus vaccine.
    Palmer MV; Waters WR; Pedersen DD; Stoffregen WC
    J Wildl Dis; 2004 Oct; 40(4):759-62. PubMed ID: 15650096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic responses to West Nile virus in vaccinated and clinically affected horses.
    Davidson AH; Traub-Dargatz JL; Rodeheaver RM; Ostlund EN; Pedersen DD; Moorhead RG; Stricklin JB; Dewell RD; Roach SD; Long RE; Albers SJ; Callan RJ; Salman MD
    J Am Vet Med Assoc; 2005 Jan; 226(2):240-5. PubMed ID: 15706975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral response to West Nile virus vaccination in alpacas and llamas.
    Kutzler MA; Baker RJ; Mattson DE
    J Am Vet Med Assoc; 2004 Aug; 225(3):414-6. PubMed ID: 15328718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of humoral response in flamingos and red-tailed hawks to experimental vaccination with a killed West Nile virus vaccine.
    Nusbaum KE; Wright JC; Johnston WB; Allison AB; Hilton CD; Staggs LA; Stallknecht DE; Shelnutt JL
    Avian Dis; 2003; 47(3):750-2. PubMed ID: 14562907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.
    Khatibzadeh SM; Gold CB; Keggan AE; Perkins GA; Glaser AL; Dubovi EJ; Wagner B
    Am J Vet Res; 2015 Jan; 76(1):92-100. PubMed ID: 25535666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).
    Wolf TM; Gandolf AR; Dooley JL; Atkinson MW; Wolfe BA
    J Zoo Wildl Med; 2008 Dec; 39(4):537-41. PubMed ID: 19110693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
    Fehér O; Bakonyi T; Barna M; Nagy A; Takács M; Szenci O; Joó K; Sárdi S; Korbacska-Kutasi O
    Vet Immunol Immunopathol; 2020 Sep; 227():110087. PubMed ID: 32629300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. West Nile virus infection in reindeer (Rangifer tarandus).
    Palmer MV; Stoffregen WC; Rogers DG; Hamir AN; Richt JA; Pedersen DD; Waters WR
    J Vet Diagn Invest; 2004 May; 16(3):219-22. PubMed ID: 15152836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge.
    Karaca K; Bowen R; Austgen LE; Teehee M; Siger L; Grosenbaugh D; Loosemore L; Audonnet JC; Nordgren R; Minke JM
    Vaccine; 2005 May; 23(29):3808-13. PubMed ID: 15893618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
    Johnson BW; Kosoy O; Martin DA; Noga AJ; Russell BJ; Johnson AA; Petersen LR
    Vector Borne Zoonotic Dis; 2005; 5(2):137-45. PubMed ID: 16011430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis).
    Redig PT; Tully TN; Ritchie BW; Roy AF; Baudena MA; Chang GJ
    Am J Vet Res; 2011 Aug; 72(8):1065-70. PubMed ID: 21801064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
    Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
    Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of assays for the detection of West Nile virus antibodies in equine serum after natural infection or vaccination.
    Joó K; Bakonyi T; Szenci O; Sárdi S; Ferenczi E; Barna M; Malik P; Hubalek Z; Fehér O; Kutasi O
    Vet Immunol Immunopathol; 2017 Jan; 183():1-6. PubMed ID: 28063471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.